DrugCite
Search

BENZODIAZEPINE DERIVATIVES

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Benzodiazepine Derivatives Adverse Events Reported to the FDA Over Time

How are Benzodiazepine Derivatives adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Benzodiazepine Derivatives, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Benzodiazepine Derivatives is flagged as the suspect drug causing the adverse event.

Most Common Benzodiazepine Derivatives Adverse Events Reported to the FDA

What are the most common Benzodiazepine Derivatives adverse events reported to the FDA?

Completed Suicide
210 (4.32%)
Multiple Drug Overdose
180 (3.7%)
Coma
154 (3.16%)
Somnolence
120 (2.47%)
Cardiac Arrest
106 (2.18%)
Respiratory Arrest
98 (2.01%)
Cardio-respiratory Arrest
82 (1.69%)
Agitation
79 (1.62%)
Drug Screen Positive
76 (1.56%)
Depressed Level Of Consciousness
72 (1.48%)
Poisoning
72 (1.48%)
Show More Show More
Lethargy
68 (1.4%)
Heart Rate Increased
60 (1.23%)
Hypotension
59 (1.21%)
Oxygen Saturation Decreased
59 (1.21%)
Aspartate Aminotransferase Increase...
57 (1.17%)
Vomiting
57 (1.17%)
Drug Abuser
52 (1.07%)
Confusional State
49 (1.01%)
Sinus Tachycardia
49 (1.01%)
Death
47 (.97%)
Alanine Aminotransferase Increased
45 (.92%)
Overdose
45 (.92%)
Blood Creatine Phosphokinase Increa...
44 (.9%)
Drug Abuse
43 (.88%)
Drug Toxicity
43 (.88%)
Intentional Drug Misuse
43 (.88%)
Suicide Attempt
42 (.86%)
Body Temperature Increased
41 (.84%)
Blood Potassium Decreased
40 (.82%)
Loss Of Consciousness
40 (.82%)
Miosis
40 (.82%)
Respiratory Depression
38 (.78%)
Tachycardia
33 (.68%)
Respiratory Rate Decreased
32 (.66%)
Rhabdomyolysis
32 (.66%)
Blood Creatinine Increased
31 (.64%)
Blood Glucose Increased
31 (.64%)
Blood Pressure Decreased
31 (.64%)
Aspiration
30 (.62%)
Pneumonia Aspiration
28 (.58%)
Respiratory Rate Increased
27 (.55%)
Blood Pressure Increased
26 (.53%)
Acidosis
25 (.51%)
Aggression
25 (.51%)
Convulsion
24 (.49%)
Multiple Drug Overdose Intentional
24 (.49%)
Blood Ph Decreased
23 (.47%)
White Blood Cell Count Increased
23 (.47%)
Blood Pressure Systolic Increased
22 (.45%)
Disorientation
22 (.45%)
Drug Withdrawal Syndrome
22 (.45%)
Hypertension
19 (.39%)
Mental Status Changes
19 (.39%)
Prothrombin Time Prolonged
19 (.39%)
Pupillary Reflex Impaired
19 (.39%)
Blood Urea Increased
18 (.37%)
Hypoxia
18 (.37%)
Mydriasis
18 (.37%)
Blood Calcium Decreased
17 (.35%)
Blood Potassium Increased
17 (.35%)
Intentional Overdose
17 (.35%)
Body Temperature Decreased
16 (.33%)
Liver Function Test Abnormal
16 (.33%)
Nausea
16 (.33%)
Pneumonia
16 (.33%)
Poisoning Deliberate
16 (.33%)
Blood Pressure Diastolic Decreased
15 (.31%)
Heart Rate Decreased
15 (.31%)
Medication Error
15 (.31%)
Pco2 Increased
15 (.31%)
Restlessness
15 (.31%)
Tremor
15 (.31%)
Alcohol Use
14 (.29%)
Drug Dependence
14 (.29%)
Dyspnoea
14 (.29%)
Electrocardiogram Qt Prolonged
14 (.29%)
Suicidal Ideation
14 (.29%)
Abnormal Behaviour
13 (.27%)
Apnoea
13 (.27%)
Blood Creatine Phosphokinase Mb Inc...
13 (.27%)
Drug Ineffective
13 (.27%)
Pyrexia
13 (.27%)
Renal Failure Acute
13 (.27%)
Blood Alkaline Phosphatase Increase...
12 (.25%)
Bradycardia
12 (.25%)
Depression
12 (.25%)
Dysarthria
12 (.25%)
Electrocardiogram Qrs Complex Prolo...
12 (.25%)
Headache
12 (.25%)
Po2 Decreased
12 (.25%)
Respiratory Failure
12 (.25%)
Areflexia
11 (.23%)
Blood Bicarbonate Decreased
11 (.23%)
Cyanosis
11 (.23%)
Haematocrit Decreased
11 (.23%)
Hyperhidrosis
11 (.23%)
Blood Bilirubin Increased
10 (.21%)
Blood Sodium Decreased
10 (.21%)
Myocardial Infarction
10 (.21%)
Substance Abuse
10 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Benzodiazepine Derivatives, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Benzodiazepine Derivatives is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Benzodiazepine Derivatives

What are the most common Benzodiazepine Derivatives adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Benzodiazepine Derivatives, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Benzodiazepine Derivatives is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Benzodiazepine Derivatives According to Those Reporting Adverse Events

Why are people taking Benzodiazepine Derivatives, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
313
Product Used For Unknown Indication
95
Ill-defined Disorder
17
Intentional Drug Misuse
13
Suicide Attempt
13
Pain
9
Show More Show More
Drug Abuse
7
Psychotic Disorder
6
Drug Abuser
5
Anxiety
4
Depression
4
Status Epilepticus
3
Nervousness
3
Premedication
3
Compulsions
2
Brief Psychotic Disorder With Marke...
2
Sedation
2
Accidental Exposure
2
Bipolar Disorder
2
Sleep Disorder
2
Completed Suicide
2
Agitation
1
Convulsion
1
Myoclonic Epilepsy
1
Dystonia
1
Crush Injury
1
Schizophrenia
1
Anorexia Nervosa
1
Arthritis
1
Suicidal Behaviour
1
Intentional Misuse
1
Substance Use
1
Sedative Therapy
1
Alcohol Withdrawal Syndrome
1
Epilepsy
1
Akathisia
1
Endotracheal Intubation
1
Back Pain
1
Major Depression
1
Injury
1
Wrong Drug Administered
1
Neurosis
1
Rib Fracture
1
Migraine
1

Benzodiazepine Derivatives Case Reports

What Benzodiazepine Derivatives safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Benzodiazepine Derivatives. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Benzodiazepine Derivatives.